神经系统疾病及相关治疗药物对骨质疏松症影响的研究进展  

Research Progress on the Influence of Nervous System Diseases and Related Therapeutic Drugs on Osteoporosis

作　　者：谭文彬 李佳 刘明玉[1,2] 路永欣 程雅欣 TAN Wenbin;LI Jia;LIU Mingyu;LU Yongxin;CHENG Yaxin(Department of Endocrinology,General Hospital of Southern Theater Command of the People's Liberation Army,Guangzhou 510010,China;The First School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Graduate School of Guangdong Pharmaceutical University,Guangzhou 510006,China)

机构地区：[1]中国人民解放军南部战区总医院内分泌科,广东省广州市510010 [2]南方医科大学第一临床医学院,广东省广州市510515 [3]广东药科大学研究生院,广东省广州市510006

出　　处：《中国全科医学》2025年第17期2092-2100,共9页Chinese General Practice

基　　金：国家重点研发计划(2021YFC2501701);广东省中央引导地方科技发展专项基金(KTP20190249)。

摘　　要：骨质疏松症(OP)患者常共患多种疾病,除了年龄、性别、种族等一般致OP危险因素外,共患疾病及其相关治疗均可对骨代谢产生影响。目前关于神经系统疾病合并OP相关研究较为缺乏,本文拟从流行病学特征、骨量流失特点、相关发病机制及诊疗进展4个方面进行综述,以期为神经系统疾病患者骨损害机制、OP预防及抗骨质疏松治疗等提供参考。Patients with osteoporosis(OP)often suffer from a variety of diseases.In addition to general risk factors such as age,gender,race,comorbidities and related treatments can affect bone metabolism.At present,there are relatively few studies on the association between neurological disorders and OP.Therefore,this article intends to review the epidemiological characteristics,bone loss feature,related pathogenesis and progress of diagnosis and treatment,in order to provide reference for the mechanism of bone damage,OP prevention and anti-osteoporosis treatment in patients with nervous system diseases.

关 键 词：骨质疏松 继发性骨质疏松症 脑卒中 脊髓损伤 多发性硬化 帕金森病 阿尔茨海默病 癫痫 治疗 综述 

分 类 号：R681[医药卫生—骨科学]